Literature DB >> 17384391

Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Chlorpromazine in migraine.

Peter Logan1, Peter Loga, David Lewis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17384391      PMCID： PMC2658244          DOI： 10.1136/emj.2007.047860

Source DB:  PubMed          Journal:  Emerg Med J        ISSN： 1472-0205            Impact factor:   2.740


× No keyword cloud information.
  8 in total

1.  Ketorolac vs chlorpromazine in the treatment of acute migraine without aura. A prospective, randomized, double-blind trial.

Authors:  M Shrestha; R Singh; J Moreden; J E Hayes
Journal:  Arch Intern Med       Date:  1996 Aug 12-26

2.  Intravenous chlorpromazine versus intramuscular sumatriptan for acute migraine.

Authors:  A M Kelly; M Ardagh; C Curry; J D'Antonio; S Zebic
Journal:  J Accid Emerg Med       Date:  1997-07

3.  A comparative trial of three agents in the treatment of acute migraine headache.

Authors:  R Bell; D Montoya; A Shuaib; M A Lee
Journal:  Ann Emerg Med       Date:  1990-10       Impact factor: 5.721

4.  Comparative efficacy of chlorpromazine and meperidine with dimenhydrinate in migraine headache.

Authors:  P L Lane; B A McLellan; C J Baggoley
Journal:  Ann Emerg Med       Date:  1989-04       Impact factor: 5.721

5.  Treatment of migraine with intramuscular chlorpromazine.

Authors:  J I McEwen; H M O'Connor; H B Dinsdale
Journal:  Ann Emerg Med       Date:  1987-07       Impact factor: 5.721

6.  Intravenous chlorpromazine vs intravenous metoclopramide in acute migraine headache.

Authors:  J D Cameron; P L Lane; M Speechley
Journal:  Acad Emerg Med       Date:  1995-07       Impact factor: 3.451

7.  Intravenous chlorpromazine in the emergency department treatment of migraines: a randomized controlled trial.

Authors:  Marcelo Eduardo Bigal; Carlos Alberto Bordini; José Geraldo Speciali
Journal:  J Emerg Med       Date:  2002-08       Impact factor: 1.484

8.  Parenteral chlorpromazine treatment of migraine.

Authors:  K V Iserson
Journal:  Ann Emerg Med       Date:  1983-12       Impact factor: 5.721
  8 in total
  2 in total

1.  Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection.

Authors:  Julie Dyall; Christopher M Coleman; Brit J Hart; Thiagarajan Venkataraman; Michael R Holbrook; Jason Kindrachuk; Reed F Johnson; Gene G Olinger; Peter B Jahrling; Monique Laidlaw; Lisa M Johansen; Calli M Lear-Rooney; Pamela J Glass; Lisa E Hensley; Matthew B Frieman
Journal:  Antimicrob Agents Chemother       Date:  2014-05-19       Impact factor: 5.191

2.  Curative Effect of Aqueous Leaf Extract of Crinum Giganteum on NMDA-Receptor Antagonist-Induced Schizophrenic Wistar Rat Model.

Authors:  Elizabeth Finbarrs-Bello; Emmanuel Nebeuwa Obikili; Esom Emmanuel Anayochukwu; Anyanwu Emeka Godson
Journal:  Open Access Maced J Med Sci       Date:  2016-08-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.